News Headlines Article

Senator scrutinizes pharma links on government pain panel
Modern Healthcare

A high-ranking Senate Democrat is scrutinizing links between pharmaceutical companies and government advisers who recently criticized efforts to reduce painkiller prescribingSen. Ron Wyden says he has “a number of concerns” about how panelists were selected and screened for an advisory panel on pain issues that includes government experts, outside academics and patient advocates. Wyden’s inquiry follows a recent Associated Press story that found nearly a third of panelists at a December meeting of the Interagency Pain Research Coordinating Committee had apparent financial ties to painkiller manufacturers, including the maker of OxyContin.

Commands